HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Joseph I. Miller, Jr Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, J. I. Articles by Phillips, T. W. Search for Related Content PubMed PubMed Citation Articles by Miller, J. I., Jr Articles by Phillips, T. W.

Ann Thorac Surg 1990;50:190-196
© 1990 The Society of Thoracic Surgeons

---

Articles

Neodymium:YAG laser and brachytherapy in the management of inoperable bronchogenic carcinoma

^a Department of Cardio-Thoracic Surgery, Woodruff Health Sciences Center, Emory University School of Medicine, Atlanta, Georgia USA
^b Division of Radiology, Crawford W. Long Memorial Hospital, Atlanta, Georgia USA

^_* Address reprint requests to Dr Miller, 25 Prescott St NE, No. 2424, Atlanta, GA 30308.

Neodymium:yttrium-aluminum garnet (Nd:YAG) laser therapy and endobronchial brachytherapy are useful modalities in the palliation of inoperable bronchogenic carcinoma. From 1983 to 1989, 218 patients underwent a total of 371 procedures involving endobronchial brachytherapy, Nd:YAG laser therapy, or both. Group 1 consisted of 130 patients who received Nd:YAG laser therapy. Group 2 consisted of 67 patients who had endobronchial brachytherapy only. Group 3 comprised 21 patients who underwent combined endobronchial brachytherapy and Nd:YAG laser therapy. All patients had received or were receiving concurrent radiotherapy. Three late deaths occurred in group 1, and 1 death occurred in group 2. More than 80% of patients achieved a good to excellent result. When applicable, we now use combined Nd:YAG laser therapy and endobronchial brachytherapy as part of the initial management of inoperable non-small cell bronchogenic carcinoma. A detailed analysis of these patients is given.

This article has been cited by other articles:

				M. E. Halkos, K. D. Godette, E. C. Lawrence, and J. I. Miller Jr High dose rate brachytherapy in the management of lung transplant airway stenosis Ann. Thorac. Surg., August 1, 2003; 76(2): 381 - 384. [Abstract] [Full Text] [PDF]

				C. D. Morris, J. M. Budde, K. D. Godette, T. L. Kerwin, and J. I. Miller Jr Palliative management of malignant airway obstruction Ann. Thorac. Surg., December 1, 2002; 74(6): 1928 - 1933. [Abstract] [Full Text] [PDF]

				C. G. Compeau and S. Keshavjee Management of Tracheal Neoplasms Oncologist, December 1, 1996; 1(6): 347 - 353. [Abstract] [Full Text] [PDF]